Venlafaxine in obsessive-compulsive disorder.
Yaryura-Tobias
J A
JA
Neziroglu
F A
FA
D018759:Adrenergic Uptake Inhibitors / Q000627:therapeutic use; D003511:Cyclohexanols / Q000627:therapeutic use*; D004311:Double-Blind Method; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy* / Q000523:psychology; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome; D000069470:Venlafaxine Hydrochloride
D018759:Adrenergic Uptake Inhibitors; D003511:Cyclohexanols; D010919:Placebos; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride